Long-term levodopa/carbidopa intestinal gel in advanced Parkinson’s disease

Neuropathy and levodopa in Parkinson's disease: Evidence from a multicenter study

(2013) Roberto Ceravolo et al.   MOVEMENT DISORDERS

Peripheral neuropathy in Parkinson's disease: Levodopa exposure and implications for duodenal delivery

(2013) Thomas Müller et al.   PARKINSONISM & RELATED DISORDERS

Polyneuropathy while on duodenal levodopa infusion in Parkinson’s disease patients: we must be alert

(2012) Diego Santos-García et al.   JOURNAL OF NEUROLOGY

Long-term duodenal levodopa infusion in Parkinson’s disease: a 3-year motor and cognitive follow-up study

(2012) Maurizio Zibetti et al.   JOURNAL OF NEUROLOGY

Weight variation before and after surgery in Parkinson's disease: A noradrenergic modulation?

(2012) Joana Guimarães et al.   MOVEMENT DISORDERS

Long-term exposure to duodenal levodopa/carbidopa infusion therapy improves quality of life in relation especially to mobility, activities of daily living, and emotional well-being

(2011) D. Santos-García et al.   ACTA NEUROLOGICA SCANDINAVICA

Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease

(2011) Anna Castrioto   ARCHIVES OF NEUROLOGY

Long-term intraduodenal infusion of a water based levodopa-carbidopa dispersion in very advanced Parkinson's disease

(2010) D. Nilsson et al.   ACTA NEUROLOGICA SCANDINAVICA

Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease

(2010) Cory Toth et al.   ANNALS OF NEUROLOGY

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

Homocysteine levels after acute levodopa intake in patients with Parkinson's disease

(2009) Thomas Müller et al.   MOVEMENT DISORDERS

Eighteen month study of continuous intraduodenal levodopa infusion in patients with advanced Parkinson's disease: Impact on control of fluctuations and quality of life

(2009) V. Puente et al.   PARKINSONISM & RELATED DISORDERS

Role of homocysteine in the treatment of Parkinson's disease

(2008) Thomas Müller   Expert Review of Neurotherapeutics

Neuropathy as a potential complication of levodopa use in Parkinson's disease

(2008) Cory Toth et al.   MOVEMENT DISORDERS